Mumps: a year of enhanced surveillance in Catalonia, Spain.
Mumps is a vaccine-preventable disease candidate for elimination. Positive predictive value (PPV) of clinical case definition was assessed. During 2007, 410 suspected cases were reported in Catalonia: 348 fulfilled clinical case definition and 159 were laboratory confirmed. Incidence rate was 4.8 per 100,000 for cases that fulfilled the clinical definition, and 2.2 for laboratory confirmed cases. Global PPV was 44.5%; 38.5% in <15 years and 50% in > or =15 years (p=0.04). Most laboratory confirmed cases (72.3%) received at least one MMR dose. With sustained high MMR coverage, laboratory confirmation is necessary to control the disease and assess vaccine failure.
Dominguez
Angela
A
Department of Public Health, University of Barcelona, Casanova 143, 08036 Barcelona, Spain. angela.dominguez@ub.edu
Oviedo
Manuel
M
Torner
Nuria
N
Carmona
Gloria
G
Costa
Josep
J
Caylà
Joan
J
Sala
M Rosa
MR
Barrabeig
Irene
I
Camps
Neus
N
Minguell
Sofia
S
Alvarez
Josep
J
Godoy
Pere
P
Jansà
Josep M
JM
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D022542:Measles-Mumps-Rubella Vaccine / Q000276:immunology; D008875:Middle Aged; D009107:Mumps / Q000453:epidemiology* / Q000517:prevention & control; D013030:Spain / Q000453:epidemiology; D014611:Vaccination
D022542:Measles-Mumps-Rubella Vaccine